Aurinia Pharmaceuticals
(NASDAQ) AUPH
Aurinia Pharmaceuticals Financials at a Glance
Market Cap
$2.16B
Revenue (TTM)
$298.30M
Net Income (TTM)
$298.21M
EPS (TTM)
$2.16
P/E Ratio
7.76
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$16.77
Volume
4,995
Open
$17.36
Price
$16.77
Volume
4,995
Open
$17.36
Previous Close
$16.79
Daily Range
$16.14 - $17.47
52-Week Range
$7.29 - $19.25
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$16.77
Volume
4,995
Open
$17.36
Previous Close
$16.79
Daily Range
$16.14 - $17.47
52-Week Range
$7.29 - $19.25
Estimated Earnings Date
Jul 30, 2026
AUPH News
AUPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aurinia Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
128
CEO
Kevin C. Tang
Website
www.auriniapharma.comHeadquarters
Edmonton, BC V8Z 7X8, CA
AUPH Financials
Key Financial Metrics (TTM)
Gross Margin
89.74%
Operating Margin
41.73%
Net Income Margin
99.97%
Return on Equity
64.48%
Return on Capital
15.99%
Return on Assets
41.19%
Earnings Yield
12.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.16B
Shares Outstanding
128.60M
Volume
5.00K
Avg. Volume
1.39M
Financials (TTM)
Gross Profit
$267.70M
Operating Income
$124.49M
EBITDA
$161.79M
Operating Cash Flow
$165.82M
Capital Expenditure
-$271.76K
Free Cash Flow
$165.55M
Cash & ST Invst.
$378.78M
Total Debt
$68.64M
Aurinia Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$77.71M
+24.4%
Gross Profit
$71.20M
+32.1%
Gross Margin
91.63%
N/A
Market Cap
$2.16B
N/A
Market Cap/Employee
$16.61M
N/A
Employees
130
N/A
Net Income
$34.36M
+47.2%
EBITDA
$49.75M
+64.4%
Quarterly Fundamentals
Total Cash
$378.78M
+21.1%
Total Debt
$68.64M
-11.9%
Accounts Receivable
$49.18M
+21.9%
Inventory
$46.41M
+0.5%
Long Term Debt
$50.50M
-19.0%
Short Term Debt
$18.14M
+16.7%
Return on Assets
41.19%
N/A
Return on Invested Capital
19.53%
N/A
Free Cash Flow
$32.52M
+2434.8%
Operating Cash Flow
$32.56M
+2404.6%